Skip to main content
Log in

Glabridin reduces neuroinflammation by modulating inflammatory signals in LPS-induced in vitro and in vivo models

  • Original Article
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Objectives

Chronic neuroinflammation has become one of the important causes of common neurodegeneration disease. Therefore, the target of this study was to explore the protective action of glabridin on lipopolysaccharide (LPS)-induced neuroinflammation in vivo and in vitro and its mechanism.

Methods

The neuroinflammation model was established by LPS-induced BV2 cells. The cell viability with various concentrations of glabridin was determined by MTT assay, and the content of NO in each group was detected. A neuroinflammatory model was established in male C57BL/6J mice for a water maze test. Subsequently, NF-κB and SOD indices were measured by ELISA, GFAP and IBA-1 indices were measured by immunofluorescence, and Nissl staining was used to explore the Nissl bodies in the hippocampus of mice.

Results

In vitro experiments, our results expressed that glabridin could markedly increase the cell activity of LPS-induced BV2 cells and reduce the NO expression in cells. It indicated that glabridin had a remarkable impact on the neuroinflammation of LPS-induced BV2 cell protection. In vivo neuroinflammation experiments, mice treated with different doses of glabridin showed significantly improved ability of memory compared with the LPS group in the Morris water maze test. The levels of NF-κB, GFAP, and the number of positive cells in Nissl staining were decreased. High-dose glabridin significantly increased the SOD content in the brain tissue and decreased the IBA-1 levels.

Conclusion

Glabridin can significantly reduce or even reverse LPS-induced neuroinflammation, which may be related to the fact that glabridin can reduce the NO expression, NF-κB, IBA-1, GFAP, and other inflammatory mediators, upregulate the expression of SOD to relieve oxidative stress of brain and inhibit the activation of gliocyte in brain tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

LPS:

Lipopolysaccharide

MTT:

Methyl-thiazolyl-tetrazolium

NO:

Nitric oxide

NF-κB:

Nuclear factor kappa-B

SOD:

Superoxide dismutase

ELISA:

Enzyme-linked immunosorbent assay

TTP488:

Azeliragon

GFAP:

Glial fibrillary acidic protein

IBA-1:

Ionized calcium-binding adapter molecule 1

DG:

Dentate gyrus

CA1:

Glutamine 1

CY3:

Cyanine3

FITC:

Fluorescein Isothiocyanate

References

Download references

Acknowledgements

This work was funded by the Guangdong Provincial Key Laboratory of Plant Resources Biorefinery (No. 2021GDKLPRB02) and the Basic and Applied Basic Research Foundation of Guangdong Province (No. 2020A1515110715).

Funding

Guangdong Provincial Key Laboratory of Plant Resources Biorefinery, 2021GDKLPRB02, Lanyue Zhang, the Basic and Applied Basic Research Foundation of Guangdong Province, 2020A1515110715, Lanyue Zhang

Author information

Authors and Affiliations

Authors

Contributions

JW: Research, digitize and write the first draft. YW: Research, digitize and write the first draft. ZT: Digitize, investigation and verification. YY: Data collation. SH: Investigation. ZL: Formal analysis. YL: Data collation and modification. LZ: Conceptualization, supervision, resources and capital acquisition. ZD: Conceptualization, methodology, supervision, review and proofreading.

Corresponding authors

Correspondence to Lanyue Zhang or Zhiyun Du.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest in the publication of this paper.

Ethical approval

All animal experiments are conducted in accordance with relevant government and institutional regulations on the ethical use of animals and are approved by the Experimental Animal Center of Guangdong Province (approval documents: SCXK/20130002).

Data availability

The data supporting the findings of this study are available from the corresponding author upon reasonable request.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weng, J., Wang, Y., Tan, Z. et al. Glabridin reduces neuroinflammation by modulating inflammatory signals in LPS-induced in vitro and in vivo models. Inflammopharmacol 32, 1159–1169 (2024). https://doi.org/10.1007/s10787-023-01424-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-023-01424-5

Keywords

Navigation